 <h1>Xenazine Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>tetrabenazine</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about tetrabenazine. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Xenazine.</p><h2>In Summary</h2><p><b>Common side effects of Xenazine include:</b> drowsiness, sedated state, bradykinesia, hypertonia, muscle rigidity, depression, exacerbation of depression, akathisia, and restlessness. <b>Other side effects include:</b> dysphagia, anxiety, and dizziness.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to tetrabenazine: oral tablet</i></p><h3>Warning</h3><p class="blackboxWarning-title">Oral route (Tablet)</p><p>Tetrabenazine can increase the risk of depression and suicidal thoughts and behavior (suicidality). This risk must be balanced with the clinical need. Monitor patients closely for clinical worsening, suicidality, or unusual changes in behavior. Families and caregivers should be advised of the need for close observation and communication with the prescriber. Particular caution should be exercised in treating patients with a history of depression or prior suicide attempts or ideation. Tetrabenazine is contraindicated in patients who are actively suicidal, and in patients with untreated or inadequately treated depression.</p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, tetrabenazine (the active ingredient contained in Xenazine) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking tetrabenazine:</p><p>
<i>More common</i>
</p><ul>
<li>Body aches or pain</li>
<li>chills</li>
<li>cough</li>
<li>difficulty in breathing</li>
<li>difficulty with swallowing</li>
<li>discouragement</li>
<li>drowsiness</li>
<li>ear congestion</li>
<li>fear or nervousness</li>
<li>feeling sad or empty</li>
<li>fever</li>
<li>headache</li>
<li>inability to sit still</li>
<li>irritability</li>
<li>lack of appetite</li>
<li>loss of balance control</li>
<li>loss of interest or pleasure</li>
<li>loss of voice</li>
<li>mask-like face</li>
<li>nasal congestion</li>
<li>need to keep moving</li>
<li>relaxed and calm</li>
<li>restlessness</li>
<li>runny nose</li>
<li>shuffling walk</li>
<li>sleepiness or unusual drowsiness</li>
<li>sleeplessness</li>
<li>slow movement or reflexes</li>
<li>slurred speech</li>
<li>sneezing</li>
<li>sore throat</li>
<li>stiffness of arms and legs</li>
<li>tic-like (jerky) movements of the head, face, mouth, and neck</li>
<li>tiredness</li>
<li>trembling and shaking of fingers and hands</li>
<li>trouble concentrating</li>
<li>trouble sleeping</li>
<li>trouble with balance</li>
<li>unable to sleep</li>
<li>unusual tiredness or weakness</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Burning while urinating</li>
<li>changes in patterns and rhythms of speech</li>
<li>cough producing mucus</li>
<li>difficult or painful urination</li>
<li>dizziness</li>
<li>shortness of breath</li>
<li>tightness in chest</li>
<li>trouble in speaking</li>
<li>trouble in walking</li>
<li>wheezing</li>
</ul><p>
<i>Get emergency help immediately if any of the following symptoms of overdose occur while taking tetrabenazine:</i>
</p><p>
<i>Symptoms of overdose</i>
</p><ul>
<li>Blurred vision</li>
<li>diarrhea</li>
<li>dizziness, faintness, or lightheadedness when getting up from a lying or sitting position suddenly</li>
<li>fixed position of the eye</li>
<li>inability to move eyes</li>
<li>increased blinking or spasms of the eyelid</li>
<li>mood or mental changes</li>
<li>nausea and vomiting</li>
<li>seeing, hearing, or feeling things that are not there</li>
<li>shakiness in legs, arms, hands, or feet</li>
<li>sticking out of tongue</li>
<li>sweating</li>
<li>trembling or shaking of hands or feet</li>
<li>uncontrolled twisting movements of neck, trunk, arms, or legs</li>
<li>unusual facial expressions</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of tetrabenazine may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Bruising</li>
<li>large, flat, blue, or purplish patches in the skin</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Decreased appetite</li>
</ul><p>
<!-- end oral tablet --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to tetrabenazine: oral tablet</i></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Any extrapyramidal event (33%), sedation/somnolence (31%), akathisia/hyperkinesia/restlessness (19%), parkinsonism (12%)</p>
<p><b>Common</b> (1% to 10%): Balance difficulty, dizziness, dysarthria, unsteady gait, headache</p>
<p><b>Uncommon</b> (0.1% to 1%): Altered levels of consciousness</p>
<p><b>Rare</b> (less than 0.1%): Neuroleptic malignant syndrome</p>
<p><b>Frequency not reported</b>: Ataxia, dyskinetic seizure, dystonia, memory impairment, amnesia</p>
<p><b>Postmarketing reports</b>: Tremor<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Fatigue (22%), fall (15%)</p>
<p><b>Common</b> (1% to 10%): Head laceration </p>
<p><b>Uncommon</b> (0.1% to 1%): Hyperthermia</p>
<p><b>Frequency not reported</b>: Lassitude, hypothermia, weakness, lactation, irregular menstrual cycle<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Very common</b> (10% or more): Insomnia (22%), depression (19%), anxiety/aggravated anxiety (15%)</p>
<p><b>Common</b> (1% to 10%): Irritability, obsessive reaction, agitation, confusion</p>
<p><b>Frequency not reported</b>: Disorientation, feelings of unreality, nervousness, sleep disorders</p>
<p><b>Postmarketing reports</b>: Worsening aggression<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (13%)</p>
<p><b>Common</b> (1% to 10%): Vomiting, dysphagia/choking attacks, constipation, diarrhea</p>
<p><b>Frequency not reported</b>: Dry mouth, epigastric pain, sialorrhea<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Upper respiratory tract infection (11%)</p>
<p><b>Common</b> (1% to 10%): Shortness of breath, bronchitis</p>
<p><b>Frequency not reported</b>: Bronchopneumonia</p>
<p><b>Postmarketing reports</b>: Pneumonia<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Hypotension</p>
<p><b>Frequency not reported</b>: Hypertensive crisis, bradycardia<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Ecchymosis</p>
<p><b>Frequency not reported</b>: Sweating</p>
<p><b>Postmarketing reports</b>: Hyperhidrosis, skin rash<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Dysuria<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Decreased appetite</p>
<p><b>Frequency not reported</b>: Anorexia, weight gain<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Uncommon</b> (0.1% to 1%): Severe extrapyramidal symptoms (e.g., muscular rigidity, autonomic dysfunction)</p>
<p><b>Very rare</b> (less than 0.01%): Skeletal muscle damage<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Frequency not reported</b>: Leukopenia<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Frequency not reported</b>: Oculogyric crisis, photophobia<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Xenazine (tetrabenazine)." Prestwick Pharmaceuticals Inc, Washington DC, VA. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about Xenazine (tetrabenazine)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>Generic Availability</li>
<li>Drug class: VMAT2 inhibitors</li>
<li>FDA Approval History</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Xenazine &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Huntington's Disease</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to tetrabenazine: oral tablet</i></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Any extrapyramidal event (33%), sedation/somnolence (31%), akathisia/hyperkinesia/restlessness (19%), parkinsonism (12%)</p><p><b>Common</b> (1% to 10%): Balance difficulty, dizziness, dysarthria, unsteady gait, headache</p><p><b>Uncommon</b> (0.1% to 1%): Altered levels of consciousness</p><p><b>Rare</b> (less than 0.1%): Neuroleptic malignant syndrome</p><p><b>Frequency not reported</b>: Ataxia, dyskinetic seizure, dystonia, memory impairment, amnesia</p><p><b>Postmarketing reports</b>: Tremor<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Fatigue (22%), fall (15%)</p><p><b>Common</b> (1% to 10%): Head laceration </p><p><b>Uncommon</b> (0.1% to 1%): Hyperthermia</p><p><b>Frequency not reported</b>: Lassitude, hypothermia, weakness, lactation, irregular menstrual cycle<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Very common</b> (10% or more): Insomnia (22%), depression (19%), anxiety/aggravated anxiety (15%)</p><p><b>Common</b> (1% to 10%): Irritability, obsessive reaction, agitation, confusion</p><p><b>Frequency not reported</b>: Disorientation, feelings of unreality, nervousness, sleep disorders</p><p><b>Postmarketing reports</b>: Worsening aggression<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (13%)</p><p><b>Common</b> (1% to 10%): Vomiting, dysphagia/choking attacks, constipation, diarrhea</p><p><b>Frequency not reported</b>: Dry mouth, epigastric pain, sialorrhea<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Upper respiratory tract infection (11%)</p><p><b>Common</b> (1% to 10%): Shortness of breath, bronchitis</p><p><b>Frequency not reported</b>: Bronchopneumonia</p><p><b>Postmarketing reports</b>: Pneumonia<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Hypotension</p><p><b>Frequency not reported</b>: Hypertensive crisis, bradycardia<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Ecchymosis</p><p><b>Frequency not reported</b>: Sweating</p><p><b>Postmarketing reports</b>: Hyperhidrosis, skin rash<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Dysuria<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Decreased appetite</p><p><b>Frequency not reported</b>: Anorexia, weight gain<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Uncommon</b> (0.1% to 1%): Severe extrapyramidal symptoms (e.g., muscular rigidity, autonomic dysfunction)</p><p><b>Very rare</b> (less than 0.01%): Skeletal muscle damage<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Frequency not reported</b>: Leukopenia<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Frequency not reported</b>: Oculogyric crisis, photophobia<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Xenazine (tetrabenazine)." Prestwick Pharmaceuticals Inc, Washington DC, VA. </p><h2>More about Xenazine (tetrabenazine)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>Generic Availability</li>
<li>Drug class: VMAT2 inhibitors</li>
<li>FDA Approval History</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Xenazine &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Huntington's Disease</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>